GROUP ONE TRADING, L.P. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$481,509
+43.3%
160,503
+17.5%
0.00%
+100.0%
Q2 2023$335,925
+240.2%
136,555
+212.5%
0.00%
Q1 2023$98,748
-80.3%
43,694
-69.6%
0.00%
-100.0%
Q4 2022$500,937
+682.7%
143,535
+4179.5%
0.00%
Q2 2022$64,000
+20.8%
3,354
+64.8%
0.00%
Q3 2021$53,000
-77.1%
2,035
-71.8%
0.00%
Q2 2021$231,000
+5.5%
7,220
+16.1%
0.00%
Q1 2021$219,0006,2200.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders